Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Modeling pulmonary fibrosis with bleomycin

(2011) Marios A. Mouratis et al.   CURRENT OPINION IN PULMONARY MEDICINE

Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis

(2010) T. Senoo et al.   THORAX

The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats

(2009) Ganlin Wu et al.   BIOMEDICINE & PHARMACOTHERAPY

Therapeutic Effect of Y-27632 on Chronic Allograft Nephropathy in Rats

(2008) Min Liu et al.   JOURNAL OF SURGICAL RESEARCH

PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation

(2007) Anna R. Hemnes et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY